World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
59
Citations
20583
World Ranking
3381
National Ranking
1562

Valder R. Arruda publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Valder R. Arruda sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 279 publications — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Valder R. Arruda D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Valder R. Arruda sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 59 D-Index — 32nd percentile

32% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Valder R. Arruda is affiliated with the University of Pennsylvania in the United States. Their research primarily focuses on medicine, with significant contributions to biochemistry, genetics, and molecular biology.

The scientist's work spans several subfields including hematology, genetics, molecular biology, oncology, and radiology, nuclear medicine, and imaging.

Main research topics include:

  • Hemophilia Treatment and Research
  • Virus-based gene therapy research
  • CAR-T cell therapy research
  • CRISPR and Genetic Engineering
  • Viral Infectious Diseases and Gene Expression in Insects
  • Platelet Disorders and Treatments
  • Blood Coagulation and Thrombosis Mechanisms

Their recent scientific papers include:

  • "Timing of Intensive Immunosuppression Impacts Risk of Transgene Antibodies after AAV Gene Therapy in Nonhuman Primates," 2020, Molecular Therapy - Methods & Clinical Development
  • "Translational Potential of Immune Tolerance Induction by AAV Liver-Directed Factor VIII Gene Therapy for Hemophilia A," 2020, Frontiers in Immunology
  • "Factor IX assay discrepancies in the setting of liver gene therapy using a hyperfunctional variant factor IX-Padua," 2021, Journal of Thrombosis and Haemostasis
  • "Evolutionary insights into coagulation factor IX Padua and other high-specific-activity variants," 2021, Blood Advances
  • "B cell-activating factor modulates the factor VIII immune response in hemophilia A," 2021, Journal of Clinical Investigation

Frequent collaborators include:

  • Timothy C. Nichols
  • Benjamin J. Samelson-Jones
  • Bhavya S. Doshi
  • Elizabeth P. Merricks
  • Katherine A. High

Their work is often published in venues such as:

  • UNC Libraries
  • Blood
  • Molecular Therapy - Methods & Clinical Development
  • Blood Advances
  • Frontiers in Immunology

Best Publications

  • Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis

    Albert M. Maguire;Francesca Simonelli;Eric A. Pierce;Edward N. Pugh

  • Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response

    Manno Cs;Pierce Gf;Arruda Vr;Glader B

  • Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector

    Mark A. Kay;Catherine S. Manno;Catherine S. Manno;Margaret V. Ragni;Peter J. Larson;Peter J. Larson

  • Geographic Distribution of the 20210 G to A Prothrombin Variant

    F.R. Rosendaal;Catharina Jacoba Maria Doggen;A. Zivelin;V.R. Arruda

  • AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B.

    Catherine S. Manno;Amy J. Chew;Sylvia Hutchison;Peter J. Larson

  • Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant.

    Lindsey A. George;Spencer K. Sullivan;Adam Giermasz;John E.J. Rasko;John E.J. Rasko

  • Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer

    Federico Mingozzi;Yi-Lin Liu;Eric Dobrzynski;Antje Kaufhold

  • Sustained phenotypic correction of hemophilia B dogs with a factor IX null mutation by liver-directed gene therapy.

    Jane D. Mount;Roland W. Herzog;D. Michael Tillson;Susan A. Goodman

  • Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism - Pooled analysis of 8 case-control studies including 2310 cases and 3204 controls

    Joseph Emmerich;Frits R. Rosendaal;Marco Cattaneo;Maurizio Margaglione

  • Long-term correction of inhibitor-prone hemophilia B dogs treated with liver-directed AAV2-mediated factor IX gene therapy.

    Glenn P. Niemeyer;Glenn P. Niemeyer;Roland W. Herzog;Jane Mount;Valder R. Arruda

  • Reversal of Blindness in Animal Models of Leber Congenital Amaurosis Using Optimized AAV2-mediated Gene Transfer

    Jeannette Bennicelli;John Fraser Wright;John Fraser Wright;Andras Komaromy;Jonathan B Jacobs

  • Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liver

    Federico Mingozzi;Nicole C. Hasbrouck;Etiena Basner-Tschakarjan;Shyrie A. Edmonson;Shyrie A. Edmonson

  • Assessing the potential for AAV vector genotoxicity in a murine model

    Hojun Li;Nirav Malani;Shari R. Hamilton;Alexander Schlachterman

  • Muscle-Directed Gene Transfer and Transient Immune Suppression Result in Sustained Partial Correction of Canine Hemophilia B Caused by a Null Mutation

    Roland W. Herzog;Jane D. Mount;Valder R. Arruda;Katherine A. High

  • Evidence of multiyear factor IX expression by AAV-mediated gene transfer to skeletal muscle in an individual with severe hemophilia B.

    Haiyan Jiang;Glenn F. Pierce;Margareth C. Ozelo;Erich V. de Paula

  • Lack of germline transmission of vector sequences following systemic administration of recombinant AAV-2 vector in males.

    Valder R. Arruda;Paul A. Fields;Ross Milner;Luanne Wainwright

  • Eradication of neutralizing antibodies to factor VIII in canine hemophilia A after liver gene therapy

    Jonathan D. Finn;Margareth C. Ozelo;Denise E. Sabatino;Helen W. G. Franck

  • Influence of vector dose on factor IX-specific T and B cell responses in muscle-directed gene therapy

    Roland W. Herzog;Paul A. Fields;Valder R. Arruda;Jeff O. Brubaker

  • Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1

    Valder R. Arruda;Joerg Schuettrumpf;Roland W. Herzog;Timothy C. Nichols

  • Role of vector in activation of T cell subsets in immune responses against the secreted transgene product factor IX.

    Paul A. Fields;Dariusz W. Kowalczyk;Valder R. Arruda;Elina Armstrong

Frequent Co-Authors

Katherine A. High
Katherine A. High Children's Hospital of Philadelphia
Roland W. Herzog
Roland W. Herzog Indiana University
J. Fraser Wright
J. Fraser Wright Stanford University
Federico Mingozzi
Federico Mingozzi Children's Hospital of Philadelphia
Mortimer Poncz
Mortimer Poncz Children's Hospital of Philadelphia
Mark A. Kay
Mark A. Kay Stanford University
Fernando F. Costa
Fernando F. Costa State University of Campinas
John E.J. Rasko
John E.J. Rasko Centenary Institute of Cancer Medicine and Cell Biology
Haig H. Kazazian
Haig H. Kazazian Johns Hopkins University School of Medicine
Michael C. Milone
Michael C. Milone University of Pennsylvania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology can open doors to various healthcare roles, including specialized nursing careers. For those interested in advanced practice nursing, exploring the cheapest pmhnp programs offers an affordable gateway into psychiatric-mental health nurse practitioner roles, combining mental health expertise with clinical skills.

Understanding salary prospects is also crucial when planning your career. Information on highest paid dnp specialties helps prospective students identify nursing paths that offer competitive compensation, supporting financially informed decisions about their educational investment.

If you’re looking to enhance your clinical expertise, consider specialized studies like acute care nurse practitioner programs. These programs help family nurse practitioners transition into acute care settings, broadening career opportunities in high-demand clinical environments.

For learners aiming to accelerate their career progress, reviewing options such as the accelerated nurse practitioner program can be a game-changer. These programs offer condensed pathways to certification, enabling quicker entry into advanced practice roles.

Best Scientists Citing Valder R. Arruda

Trending Scientists

Recently Published Articles